Aurora Cannabis Inc. shares rose Tuesday, after the Canadian company said it has entered a multiyear, multimillion-dollar agreement with mixed martial arts organization UFC to research the effect of hemp-derived CBD products on athlete recovery and wellness.

The companies have agreed to conduct the research at UFC’s Las Vegas institute, setting up clinical studies to evaluate CBD, a nonintoxicating ingredient in cannabis and hemp, as a treatment for pain management, inflammation, injury/exercise recovery and mental well being. Aurora sharesACB, +2.00% ACB, -0.77%  rose 3%.

The Montreal Children's Hospital is reminding parents to keep their edibles locked up and away from kids following an increase in the number of cannabis intoxication cases.

Between 1990 and 2016, it was relatively rare for doctors at the hospital to treat children under the age of seven who had ingested cannabis — one case, on average, every three years.

But since 2016, when talk of the legalization of marijuana ramped up, nine children under the age of seven have been treated after consuming the drug.

Cannabis genetics is something that’s been heavily worked and experimented on in the past three decades. It is very rare that we get to see something like herbal genetics being perfected in illegal greenhouses, and yet here we are.

The growers perfected their plants’ genetics by handpicking only the best, strongest and most potent phenotypes and crossed them with their peers. That is how we got extremely potent strains such as OG Kush and many others.

As we all know, part of the festivities may include certain substances, two of them likely cannabis and alcohol.

On a night out at a bar, chances are high that at some point somebody will whip out a joint.

According to Public Health Ontario, combined use of cannabis and alcohol is the most common form of poly-substance use.

But what exactly happens when the two substances are combined?

Read on for an in-depth look at how cannabis and alcohol mix together and the risks to be aware of.

Primarily known for operating dispensaries in Florida, Trulieve Cannabis Corp. (CSE: TRUL) today announced plans to expand into Connecticut by acquiring an existing storefront. 

Trulieve just entered an agreement to snap up 100% of Bristol-based medical cannabis dispensary The Healing Corner, which has operated in the city since 2014.  

Medical marijuana usage was officially legalized in Connecticut back in 2012. While various bills have been proposed to legalize recreational usage in both 2018 and early 2019, none of them have yet gathered enough support to be passed and hit the governor’s desk. 

The number of current cannabis users who have consumed cannabis before and during work is alarming and should not be taken lightly by employers, says Ryan Mallough, director of provincial affairs, Ontario for the Canadian Federation of Independent Business (CFIB). “500,000 Canadians is not nothing,” says Mallough. “It is an issue that employers should be aware of.”

Over the last year, Canada approved cannabis.  More U.S. states are legalizing its recreational or medicinal use. Corporate America is using CBD and hemp oil in everything from lotions and pain balm to beverages. President Trump signed the 2018 Farm Bill into law. Even better, according to Arcview Market Researcher and BDS Analytics, global spending on cannabis is expected to rocket 38% this year to $16.9 billion up from $12.2 billion in 2018. 

Jefferies has projected that the cannabis industry will be worth US$130.0B in a decade if the industry expands to sectors such as alcohol, health and wellness and pet care. In U.S. for 2018, US$72.56B was spent on pets with US$18.1B attributed to vet care and US$30.3B spent on food (American Pet Products Association, 2018).

The pet market is being driven by increasing pet humanization trends and increasing dog ownership. CBD products for pets can help treat anxiety, chronic pain and skin aliments, among others. Today we have identified four cannabis CBD stocks that may have an early leg up in the CBD pet care market.

Cronos Group Inc (TSE:CRON) (NASDAQ:CRON) shares popped Tuesday after the company announced an agreement with cannabis supplier MediPharm Labs Corp (TSE:LABS) (OTCMKTS:MEDIF).

MediPharm will supply Peace Naturals, a wholly owned Cronos subsidiary, with $30 million worth of cannabis concentrate over 18 months with options to increase to as much as $60 million over 24 months.

CBD brand ratings by a popular CBD products directory show three brands with top ratings and two brands receiving ratings downgrades. Additionally, three new product ratings have been released this month. Among the top brands is a pure organic brand offered as both a Softgel capsule and as a concentrated liquid, see here https://cbdrevu.com/cbdpure-hemp-oil-cbd/.